Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2025	Jul. 31, 2024	Jul. 31, 2023
Cash flows from operating activities:
Net income	$ 1,856	$ 1,735	$ 1,889
Depreciation and amortization	373	335	321
Share-based compensation	28	49	51
Non-cash impact of impairments	0	0	125
Changes in deferred income taxes	(39)	125	(104)
Changes in inventories	(273)	(252)	607
Changes in receivables and other assets	(321)	(98)	(1)
Changes in accounts payable and other liabilities	278	11	(196)
Changes in income taxes payable	7	(45)	24
Other operating activities	(1)	13	11
Net cash provided by operating activities of continuing operations	1,908	1,873	2,727
Net cash used in operating activities of discontinued operations	0	0	(4)
Net cash provided by operating activities	1,908	1,873	2,723
Cash flows from investing activities:
Purchase of businesses acquired, net of cash acquired	(301)	(260)	(616)
Capital expenditures	(305)	(372)	(441)
Other investing activities	63	31	3
Net cash used in investing activities	(543)	(601)	(1,054)
Cash flows from financing activities:
Purchase of treasury shares	(948)	(634)	(908)
Proceeds from sale of treasury shares	0	17	17
Repayments of debt	(4,400)	(2,110)	(2,930)
Proceeds from debt	4,621	2,255	2,775
Change in bank overdrafts	4	(16)	(15)
Cash dividends	(489)	(784)	(711)
Other financing activities	(74)	(41)	(35)
Net cash used in financing activities	(1,286)	(1,313)	(1,807)
Change in cash, cash equivalents and restricted cash	79	(41)	(138)
Effects of exchange rate changes	3	(3)	22
Cash, cash equivalents and restricted cash, beginning of period	625	669	785
Cash, cash equivalents and restricted cash, end of period	707	625	669
Supplemental Disclosures:
Cash paid for income taxes	601	651	656
Cash paid for interest	189	188	182
Accrued capital expenditures	14	6	17
Accrued dividends	$ 163	$ 0	$ 152